Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid β-oxidation

Journal of Inherited Metabolic Disease

Volumn 31, Issue 3, 2008, Pages 442-449

  Morita, Masa ^a   Kanai, M ^a   Mizuno, S ^a   Iwashima, M ^a   Hayashi, T ^a   Shimozawa, N ^b   Suzuki, Y ^c   Imanaka, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; BAICALEIN; CLOMOXIR; FATTY ACID; FATTY ACID TRANSPORTER 4; LIGNOCERIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITIC ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; CANCER CELL; CELL STIMULATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISORDERS OF PEROXISOMAL FUNCTIONS; DRUG ACTIVATION; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID OXIDATION; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; MITOCHONDRION; PEROXISOME; PROTEIN EXPRESSION; ZELLWEGER SYNDROME;

ADRENOLEUKODYSTROPHY; ATP-BINDING CASSETTE TRANSPORTERS; CARNITINE ACYLTRANSFERASES; CELLS, CULTURED; COENZYME A LIGASES; EPOXY COMPOUNDS; FATTY ACIDS; FIBROBLASTS; FLAVANONES; GLIOBLASTOMA; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; PEROXISOMES; ZELLWEGER SYNDROME;

EID: 45849111823     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0857-2     Document Type: Article

References (35)

1. de Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F (1955) Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J 60: 604-617.
2. Dubois-Dalcq M, Feigenbaum V, Aubourg P (1999) The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 22: 4-12.
3. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
4. Heinzer AK, Kemp S, Lu JF, Watkins PA, Smith KD (2002) Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy. J Biol Chem 277: 28765-28773.
5. Heinzer AK, Watkins PA, Lu JF et al (2003) A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12: 1145-1154.
6. Holzinger A, Kammerer S, Berger J, Roscher AA (1997) cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter. Biochem Biophys Res Commun 239: 261-264.
7. Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26: 851-860.
8. Imanaka T, Aihara K, Takano T, et al (1999) Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter. J Biol Chem 274: 11968-11976.
9. Jia Z, Pei Z, Li Y, Wei L, Smith KD, Watkins PA. (2004) X-linked adrenoleukodystrophy: Role of very long-chain acyl-CoA synthetases. Mol Genet Metab 83: 117-127.
10. Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA (2007) Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 282: 20573-20583.
11. Kamijo K, Kamijo T, Ueno I, Osumi T, Hashimoto T (1992) Nucleotide sequence of the human 70 kDa peroxisomal membrane protein: A member of ATP-binding cassette transporters. Biochim Biophys Acta 1129: 323-327.
12. Kemp S, Wei HM, Lu JF, et al (1998) Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy. Nat Med 4: 1261-1268.
13. Kemp S, Valianpour F, Denis S, et al (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84: 144-151.
14. Koike R, Tsuji S, Ohno T, Suzuki Y, Orii T, Miyatake T (1991) Physiological significance of fatty acid elongation system in adrenoleukodystrophy. J Neurol Sci 103: 188-194.
15. Kurisu M, Morita M, Kashiwayama Y, et al (2003) Existence of catalase-less peroxisomes in Sf21 insect cells. Biochem Biophys Res Commun 306: 169-176.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
17. McGuinness MC, Lu JF, Zhang HP, et al (2003) Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol Cell Biol 23: 744-753.
18. Milger K, Herrmann T, Becker C, et al (2006) Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci 119: 4678-4688.
19. Morita M, Takahashi I, Kanai M, et al (2005) Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid β-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy. FEBS Lett 579: 409-414.
20. Mosser J, Douar AM, Sarde CO, et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726-730.
21. Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J (1999) Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): Implications for therapy. Hum Mol Genet 8: 907-913.
22. Petroni A, Cappa M, Carissimi R, Blasevich M, Uziel G (2007) Effect of testosterone metabolites on ABC half-transporter relative gene expression in X-linked adrenoleukodystrophy. J Inherit Metab Dis 30: 828.
23. Pujol A, Ferrer I, Camps C, et al (2004). Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: A therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13: 2997-3006.
24. Rizzo WB, Watkins PA, Phillips MW, Cranin D, Campbell B, Avigan J (1986) Adrenoleukodystrophy: Oleic acid lowers fibroblast saturated C22-26 fatty acids. Neurology 36: 357-361.
25. Singh I, Moser AE, Moser HW, Kishimoto Y (1984) Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res 18: 286-290.
26. Singh I, Khan M, Key L, Pai S (1998a) Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med 339: 702-703.
27. Singh I, Pahan K, Khan M (1998b) Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy. FEBS Lett 426: 342-346.
28. Steinberg SJ, Morgenthaler J, Heinzer AK, Smith KD, Watkins PA (2000) Very long-chain acyl-CoA synthetases. Human "bubblegum" represents a new family of proteins capable of activating very long-chain fatty acids. J Biol Chem 275: 35162-35169.
29. Steinberg SJ, Wang SJ, Kim DG, Mihalik SJ, Watkins PA (1999) Human very-long-chain acyl-CoA synthetase: Cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochem Biophys Res Commun 257: 615-621.
30. Suzuki Y, Shimozawa N, Yajima S, Yamaguchi S, Orii T, Hashimoto T (1991) Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem Pharmacol 41: 453-456.
31. Takemoto Y, Suzuki Y, Tamakoshi A, et al (2002) Epidemiology of X-linked adrenoleukodystrophy in Japan. J Hum Genet 47: 590-593.
32. Uchiyama A, Aoyama T, Kamijo K, et al (1996) Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J Biol Chem 271: 30360-30365.
33. Wanders RJ (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83: 16-27.
34. Watkins PA (1997) Fatty acid activation. Prog Lipid Res 36: 55-83.
35. Watkins PA, Ferrell EV Jr, Pedersen JI, Hoefler G (1991) Peroxisomal fatty acid β-oxidation in HepG2 cells. Arch Biochem Biophys 289: 329-336.